We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A combination therapy of tobramycin and ...

BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 12, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced the FDA approval of prednisolone ...

A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...

Amneal Pharmaceuticals has announced the FDA approval of its prednisolone acetate ophthalmic suspension, a 1% sterile topical anti-inflammatory treatment intended for steroid-responsive ocular ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) Thursday said that the U.S. Food and Drug Administration (FDA) has approved prednisolone acetate ophthalmic suspension, a generic version of Allergan's ...

Amneal has received clearance from the Food and Drug Administration for prednisolone acetate ophthalmic suspension 1% sterile, which is a generic of Allergan’s Pred Forte. Launch of the product is ...

We thank Drs. Kaur and Sukhija for their interest in our article. They make several interesting and important points in their letter. They mention that difluprednate is a highly potent steroid that ...

We found that the incidence of spontaneous myeloid leukemia in C3H/He male mice was less than 1%, but it could be increased considerably by total-body X irradiation. The induction of myeloid leukemia ...

The effect of androgen receptor splice variant 7 on the growth of castration-resistant prostate cancer and the efficacy of taxane chemotherapy. This is an ASCO Meeting Abstract from the 2019 ...

E.S. (M.G.H. 876315), a 52-year-old woodsman with acrodermatitis continua (Hallopeau), was admitted to the Massachusetts General Hospital on November 8, 1954, because of a dermatosis involving the ...

Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal ...